Alnylam Pharmaceuticals
ALNY
#634
Rank
A$49.01 B
Marketcap
$380.05
Share price
-0.80%
Change (1 day)
52.30%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company